ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief; Jerome Green To Head NIH Div. Of Research Grants; M.D. Anderson’s Even Hersh To Join Univ. of Arizona

December 13, 1985

Consensus Conference On Receptors Planned

June 22, 1979

ACS Says Its Goals, Patients’ Coalition, Similar, Supports Bill

March 15, 1996

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

Chemical Carcinogenesis

November 18, 1994

BRCA Mutations In About 2% Of Breast Cancer Patients

August 25, 2006